Assessment of Paclitaxel Induced Sensory Polyneuropathy with "Catwalk" Automated Gait Analysis in Mice

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Huehnchen, Petra ^a   Boehmerle, Wolfgang ^a   Endres, Matthias ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PACLITAXEL;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATWALK TEST; CONTROLLED STUDY; DOSE DENSIFICATION; DRUG EFFECT; ELECTROPHYSIOLOGY; EXPERIMENTAL TEST; GAIT; MALE; MOTOR PERFORMANCE; MOUSE; NERVE POTENTIAL; NONHUMAN; POLYNEUROPATHY; ROTAROD TEST; SENSORY POLYNEUROPATHY; TREATMENT OUTCOME;

AMINES; ANIMALS; ANTINEOPLASTIC AGENTS; AUTOMATION; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAIT; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MICE, INBRED C57BL; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHIES;

EID: 84885448309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076772     Document Type: Article

References (39)

1. Windebank AJ, Grisold W, (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13: 27-46.
2. Authier N, Balayssac D, Marchand F, Ling B, Zangarelli A, et al. (2009) Animal models of chemotherapy-evoked painful peripheral neuropathies. Neurotherapeutics 6: 620-629.
3. Ochoa JL, (1994) Pain mechanisms in neuropathy. Curr Opin Neurol 7: 407-414.
4. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL, (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.
5. Cunha TM, Verri WA Jr, Vivancos GG, Moreira IF, Reis S, et al. (2004) An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37: 401-407.
6. Sato J, Morimae H, Seino Y, Kobayashi T, Suzuki N, et al. (1999) Lowering barometric pressure aggravates mechanical allodynia and hyperalgesia in a rat model of neuropathic pain. Neurosci Lett 266: 21-24.
7. Kim KJ, Yoon YW, Chung JM, (1997) Comparison of three rodent neuropathic pain models. Exp Brain Res 113: 200-206.
8. Vrinten DH, Hamers FF, (2003) 'CatWalk' automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat; a comparison with von Frey testing. Pain 102: 203-209.
9. Bozkurt A, Deumens R, Scheffel J, O'Dey DM, Weis J, et al. (2008) CatWalk gait analysis in assessment of functional recovery after sciatic nerve injury. J Neurosci Methods 173: 91-98.
10. Deumens R, Jaken RJ, Marcus MA, Joosten EA, (2007) The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection. J Neurosci Methods 164: 120-130.
11. Gabriel AF, Marcus MA, Honig WM, Walenkamp GH, Joosten EA, (2007) The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods 163: 9-16.
12. Ferland CE, Laverty S, Beaudry F, Vachon P, (2011) Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav 97: 603-610.
13. Quasthoff S, Hartung HP, (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249: 9-17.
14. Katsumata N, (2011) Dose-dense therapy is of benefit in primary treatment of ovarian cancer? In favor. Ann Oncol 22Suppl 8: viii29-viii32.
15. Sparano JA, Wang M, Martino S, Jones V, Perez EA, et al. (2008) Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358: 1663-1671.
16. Xiao W, Boroujerdi A, Bennett GJ, Luo ZD (2007) Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144: 714-720. Epub 2006 Nov 2002.
17. Atas A, Agca O, Sarac S, Poyraz A, Akyol MU, (2006) Investigation of ototoxic effects of Taxol on a mice model. Int J Pediatr Otorhinolaryngol 70: 779-784.
18. Koopmans GC, Deumens R, Brook G, Gerver J, Honig WM, et al. (2007) Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol Behav 92: 993-1001.
19. Cendelin J, Voller J, Vozeh F, (2010) Ataxic gait analysis in a mouse model of the olivocerebellar degeneration. Behav Brain Res 210: 8-15.
20. Wang MS, Davis AA, Culver DG, Glass JD, (2002) WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann Neurol 52: 442-447.
21. Naujokat C, Steinhart R, (2012) Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol 2012: 950658.
22. Reagan-Shaw S, Nihal M, Ahmad N, (2008) Dose translation from animal to human studies revisited. FASEB J 22: 659-661.
23. Hess V, Verrill MW, Bomphray CC, Vaughan MM, Allen M, et al. (2003) Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma. Ann Oncol 14: 638-642.
24. Smith SB, Crager SE, Mogil JS, (2004) Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains. Life Sci 74: 2593-2604.
25. Wang MS, Davis AA, Culver DG, Wang Q, Powers JC, et al. (2004) Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 127: 671-679. Epub 2004 Feb 2004.
26. Mo M, Erdelyi I, Szigeti-Buck K, Benbow JH, Ehrlich BE (2012) Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment. FASEB J.
27. Polomano RC, Mannes AJ, Clark US, Bennett GJ, (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94: 293-304.
28. Leandri M, Ghignotti M, Emionite L, Leandri S, Cilli M, (2012) Electrophysiological features of the mouse tail nerves and their changes in chemotherapy induced peripheral neuropathy (CIPN). J Neurosci Methods 209: 403-409.
29. Scripture CD, Figg WD, Sparreboom A, (2006) Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Curr Neuropharmacol 4: 165-172.
30. Carozzi VA, Canta A, Oggioni N, Sala B, Chiorazzi A, et al. (2010) Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies. Exp Neurol 226: 301-309.
31. Lindenlaub T, Teuteberg P, Hartung T, Sommer C, (2000) Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res 866: 15-22.
32. Piesla MJ, Leventhal L, Strassle BW, Harrison JE, Cummons TA, et al. (2009) Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models. Brain Res 1295: 89-98.
33. Boroujerdi A, Kim HK, Lyu YS, Kim DS, Figueroa KW, et al. (2008) Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain 139: 358-366.
34. Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, et al. (2002) Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303: 1199-1205.
35. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, et al. (2001) Upregulation of dorsal root ganglion (alpha) 2 (delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 21: 1868-1875.
36. Newton RA, Bingham S, Case PC, Sanger GJ, Lawson SN, (2001) Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury. Brain Res Mol Brain Res 95: 1-8.
37. Matsumoto M, Inoue M, Hald A, Xie W, Ueda H (2006) Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 318: 735-740. Epub 2006 May 2010.
38. Gauchan P, Andoh T, Ikeda K, Fujita M, Sasaki A, et al. (2009) Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha (2) delta-1 subunit. Biol Pharm Bull 32: 732-734.
39. Mogil JS, Crager SE, (2004) What should we be measuring in behavioral studies of chronic pain in animals? Pain 112: 12-15.